missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Novex™ Recombinant Protein G - Sepharose™ 4B
Recombinant Protein G - Sepharose™ 4B
Brand: Novex™ 101241
This item is not returnable.
View return policy
Description
Recombinant protein G is produced in a strain of E. coli which contains the gene for protein G from Streptococcus sp. This product is prepared by covalently coupling highly purified rec-Protein G to Sepharose™ 4B. It is supplied as a 50% suspension containing rec-Protein G-Sepharose™ 4B + PBS (10 mM phosphate-buffered saline, pH 7.4, containing 0.1% Proclin).Applications: Immunoglobulin affinity purification and Immunoprecipitation.
Recombinant protein G binds to the Fc region of many types of immunoglobulin G including:
Recombinant protein G does not bind to IgG from chicken or cat, or to human IgA, IgM, or serum albumin. It binds weakly to IgG from dog.

Specifications
Protein G Sepharose | |
Affinity | |
This product is supplied as a 50% suspension (2 ml Recombinant Protein G-Sepharose™ 4B + 2 ml PBS) Wet Ice | |
Suspension |
Sepharose™ | |
Protein G | |
2 mL |
Product Suggestions
Customers who viewed this item also viewed.
Viewing 1-5 of 12
Rec. Protein G - Sepharose 4B
Version: 06/10
File size: 38.9 kB
Certificates
A lot number is required to show results for certificates. To find your lot number on previous orders use our order status area.
5 results found
Lot Number | Certificate Type | Date | Catalog Number |
---|---|---|---|
ZK404856 | Certificate of Analysis | 08/11/2024 | 101241 |
YI366844 | Certificate of Analysis | 22/09/2023 | 101241 |
XI361007 | Certificate of Analysis | 08/10/2022 | 101241 |
XC333211 | Certificate of Analysis | 14/05/2022 | 101241 |
WE324088 | Certificate of Analysis | 04/06/2021 | 101241 |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Novex™ Recombinant Protein G - Sepharose™ 4B > 2mL
For Research Use Only. Not for use in diagnostic procedures.
Spot an opportunity for improvement?Share a Content Correction